PhenoMx is a health technology company, commercializing a personalized digital physical examination to help predict disease risks, by directly measuring the major vital organs & tissues from a whole body perspective, utilizing: non-invasive medical imaging to acquire data, automation algorithms to quantify images, and artificial intelligence to develop predictive analytics for improved health and longevity.

FundRx is a venture capital platform that builds and invests in the next-generation of healthcare and life sciences startups. Our community of hundreds of venture partners – themselves physicians, scientists, and industry executives – contribute their capital, time, and expertise to the FundRx portfolio, providing exceptional hands-on support and guidance to nurture great companies. We take a scientific approach to investing, working with a distributed network of experts to peer-review prospective startups, and are a pioneer in venture capital technology – with a dedicated engineering organization enabling advanced analytics and screening of investments. We are headquartered in New York City, with offices in Chicago and San Francisco.

Our Advisory Board is comprised of leading experts in disruptive technologies in their field. They work with us to create relevant conference session content to give our participants the information and ideas they need to succeed in the respective industry.

Providing education resource for global health care 3D printing, bioprinting community, including companies and investors interested in space and healthcare providers actually using the technology.Grow cohesiveness as a global community where members can collaborate on projects and exchange information effectively.Discover local innovators/startups, esp those looking for growth/funding.

The PEMED 2020 Scientific Committee is composed of experienced Professors and Doctors who are in charge of assessing the submitted papers based on the peer review method. Its members will be listed soon below.

AAPM Coronavirus Taskforce (ACT!): Global Taskforce working on finding prevention strategies, diagnostics and a cure for the deadly Corona Virus.

The Downtown Boathouse is an all-volunteer nonprofit organization dedicated to providing free public access to the harbor in New York City through public kayaking programs. Our mission is to encourage safe public use of the harbor waters of New York City and thereby provide residents of this space-constrained city with increased recreational opportunities. Our operations are made possible through volunteers and with your public donations and support.

The High Line is a public park built on a historic freight rail line elevated above the streets on Manhattan’s West Side. It runs from Gansevoort Street in the Meatpacking District to West 34th Street, between 10th and 12th Avenues.Through excellence in operations, stewardship, innovative programming, and world-class design, we seek to engage the vibrant and diverse community on and around the High Line, and to raise the essential private funding to help complete the High Line's construction and create an endowment for its future operations.Friends of the High Line raises the funding to maintain and operate the High Line and its programs from both private and public sources.

The IRC is an Imaging CRO for Academic Researchers and Pharma, Biotech, or Medical Device Scientists who would like to develop or implement Advanced Imaging Biomarkers. By utilizing a translational research approach, we facilitate your compound development from preclinical to late stage trials. Our imaging analytics platform will improve your chances for a successful outcome and advancement of your research goals.

The Personalized and Precision Medicine International Conference (PEMED 2018) will be held in Paris on June 25-27th 2018! This event aims at gathering the best experts and will enable the delegates to attend high-quality presentations and talks.

Business, Scientific, and Technical Advisor for Precision Medicine

Lyscaut is an independent Medical Imaging Company offering end-to-end image handling services on behalf of Hospitals (teleradiology & telemedicine), Pharma / BioTech / CROs (image-based clinical trials) and Collaborative Research (clinical decision support & workflow optimisation) having offices in the Netherlands, Belgium, France and the UK. Lyscaut is affiliated to the Swedish medical technology company Hermes Medical (www.hermesmedical.com) for mobile technology, cloud storage and image logistics & processing. Also, Lyscaut has partnered with the Germany based medical technology company ClinFlows (www.clinflows.de) offering their "decidemedical" platform for both clinical decision support and advanced communication, notification & messaging.Lyscaut partners with its Clients (hospitals / imaging centers / outpatient clinics / small and middle sized BioTech, Pharma & CROs) to leverage the latest image transport, visualization and analysis technologies to improve productivity and operate more efficiently. The business model centers on the Client and the ability to pull multiple strategic business partnerships together to help Clients accomplish their goals. These partnerships may vary from accredited uniform reading networks, medical software & data management to workflow automation & hospital infrastructure.Lyscaut - the medical interface and prime contractor to the Client - starts out listening and then provides a customized solution (service, support or license) with a focus on a seamless fit avoiding duplication and bringing down costs"We care for your images, it's what we do".Key words: bariatric, bone, brain, cardiology, devices, internal medicine, msk, neurology, oncology, pathology, projects, psychiatry, scientific, surgery & women's health.

Key leaders from digital health, medical research, pharma, healthcare, digital security, academia, startups and investing have convened for interactive discussions in a by-invitation symposium to spur the growth of a healthtech ecosystem in New York.

Mission and Goals Pennsylvania Bio’s mission is to ensure Pennsylvania is the United States hub for the life sciences by creating a business and public policy environment which fosters life sciences growth and success.Vision 2017Pennsylvania is considered the most attractive location in the United States for establishing a life sciences organization by life sciences leaders within the U.S. and by those outside the U.S. seeking to establish U.S. operationsWho We ArePennsylvania Bio was founded 26 years ago by a group of Biotech CEOs. Today it’s grown to represent the entire life sciences industry – medical device companies, pharmaceutical companies, investment organizations, research institutions, and myriad service industries that support the life sciences in Pennsylvania.What We DoPA Bio delivers two valuable services – public policy clout, and strategic connections that can advance you and your organization.Our public policy work in both Harrisburg and Washington ensures that all of our members are heard by those who make legislative decisions.PA Bio provides members with unparalleled networking opportunities to facilitate strategic connections. Our array of both large and small events throughout the year, along with our partnership with BioNJ and the strategic group buying program, ensure that our members stay connected, 365-24-7.

Evaluation of Probability Mapping for Cardiac Scar Tissue

NewYorkBIO supports the development and growth of New York State's life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development.NewYorkBIO brings together over 250 of New York’s bioscience companies, universities, research institutions, and others dedicated to advancing life science research and commercialization. We are the leading advocate for our industry in New York State.We drive innovation and support the development and growth of New York State’s life science industry, our members, and the community by providing a network for information exchange, shared services, and collective action.

Evaluation of MagnePath Pty Ltd Technology (FatMap, LiverMap, MuscleMap) for Commercialization in the USA.

The Entrepreneurship Lab is a competitive 6-month Program launched by the City of New York, designed for graduate students of science, engineering and medicine, post-doctoral fellows, medical residents, physicians, nurses and other scientists, researchers and technologists in NYC and interested in forming new ventures in the life sciences and healthcare technology sectors.The Entrepreneurship Lab is an initiative of the Bloomberg Administration and the City of New York. In a strategic review of the life sciences and healthcare sectors in NYC, the New York City Economic Development Corporation (NYCEDC) held extensive conversations with senior academic stakeholders, investors and entrepreneurs in NYC and beyond. There was consensus that the City can play a more active role in championing an entrepreneurial culture among NYC’s academic research and clinical care communities.